What is the recommended dosing schedule for chlorpromazine (Cpz) in adults, including starting dose, titration increments, maximum daily dose, and adjustments for elderly or hepatic impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chlorpromazine Dosing

For adults with psychotic disorders, start chlorpromazine at 25 mg three times daily (or 10-25 mg for outpatients), titrate gradually based on response, with typical effective doses ranging from 200-400 mg/day, and use the lower end of the dosing range (12.5-25 mg) for elderly patients or those with hepatic impairment. 1

Starting Doses by Clinical Setting

Outpatients with Psychosis

  • Initial dose: 10 mg three times daily OR 25 mg twice to three times daily 1
  • For more severe outpatient cases: 25 mg three times daily, then increase by 20-50 mg at semi-weekly intervals until calm and cooperative 1

Hospitalized Patients

  • Acute schizophrenia/mania: Start with injectable chlorpromazine until controlled (usually 24-48 hours), then switch to oral 25-50 mg three times daily, increasing gradually until patient is calm 1
  • Less acutely disturbed: 25 mg three times daily, increase gradually until effective dose reached (usually 400 mg daily) 1

Delirium Management (Cancer/Palliative Care Context)

  • Starting dose: 12.5-25 mg PO or PR stat 2
  • Scheduled dosing if needed: Give every 6-12 hours 2
  • Can also be given slow IV (diluted), IV infusion, or deep IM injection 2

Titration Strategy

The FDA label provides clear guidance: increase dosage gradually until symptoms are controlled, with more gradual increases in debilitated or emaciated patients 1. For hospitalized patients with severe cases, daily dosage may be increased by 20-50 mg at semi-weekly intervals 1.

Maximum improvement may not be seen for weeks or even months 1. Continue optimum dosage for 2 weeks, then gradually reduce to the lowest effective maintenance level 1.

Maximum Daily Doses

  • Typical effective range: 200-400 mg/day 1
  • Discharged mental patients: 800 mg daily is not uncommon 1
  • Hospitalized patients: 500 mg/day is generally sufficient, though gradual increases to 2,000 mg/day may be necessary in some cases 1
  • Important caveat: There is usually little therapeutic gain achieved by exceeding 1,000 mg/day for extended periods 1

Research evidence supports this conservative approach: a Cochrane review found that low doses (≤400 mg/day) had similar efficacy to medium doses (401-800 mg/day) but with significantly fewer extrapyramidal symptoms 3. When compared to high doses (>800 mg/day), the high-dose group showed some improvement in global state but had significantly more people leaving due to disabling adverse effects 3.

Special Population Adjustments

Elderly Patients

Use doses in the lower range as elderly patients appear more susceptible to hypotension and neuromuscular reactions 1.

  • Delirium context: 12.5-25 mg in the lower range 2
  • Insomnia (palliative care): 25-50 mg PO at bedtime, adjustable to 25-100 mg at bedtime 4
  • Dosage should be tailored individually, response carefully monitored, and dosage increased more gradually 1

In a study of elderly schizophrenic veterans, chlorpromazine was titrated to a maximum of 600 mg/day with careful monitoring, demonstrating both efficacy and tolerability when properly managed 5.

Hepatic Impairment

Use with caution in patients with hepatic impairment 2. The guidelines recommend using doses in the lower range, though specific dose reductions are not quantified. Start conservatively and titrate slowly while monitoring for adverse effects.

Renal Impairment

Use with caution in patients with renal impairment 2, though less emphasis is placed on renal dosing compared to hepatic considerations.

Route-Specific Dosing

Oral (PO)

Standard route with dosing as above.

Rectal (PR)

  • Delirium: 12.5-25 mg stat, then every 6-12 hours if scheduled dosing required 2
  • Palliative sedation: 25-100 mg every 4-12 hours, with usual effective dose of 75-300 mg/day 6

Intravenous (IV)

  • Must be given slowly (diluted) or as IV infusion 2
  • Palliative sedation: 12.5 mg every 4-12 hours, or 3-5 mg/hour IV 6
  • Parenteral use may cause local irritation 2

Intramuscular (IM)

  • Deep IM injection required 2
  • Palliative sedation: 12.5 mg every 4-12 hours, with usual effective dose of 37.5-150 mg/day 6

Maintenance Dosing

After symptoms are controlled for a reasonable period, gradually reduce dosage to the lowest effective maintenance level 1. Daily dosage of 200 mg is not unusual for maintenance 1.

Common Pitfalls and Caveats

Adverse Effects to Monitor

  • Sedating and anticholinergic effects 2
  • Extrapyramidal symptoms (EPSEs) - risk increases with dose 2
  • Orthostatic hypotension - particularly problematic in elderly 2
  • QTc prolongation 2
  • Paradoxical agitation 6

Contraindications

  • Do not use in patients with Parkinson's disease or dementia with Lewy bodies (though this is more specific to haloperidol, typical antipsychotics as a class carry this risk) 2

Dosing Philosophy

The average dose of chlorpromazine has declined dramatically over 60 years, from very high doses (>800 mg/day) to current conservative approaches (200-400 mg/day), though this change came from clinical experience rather than high-quality trial evidence 3, 7. The Cochrane review notes that "this progression towards gentler levels of dosing has taken six decades" 7.

Pediatric Dosing (6 months to 12 years)

  • Severe behavioral problems (outpatients): 0.25 mg/lb body weight every 4-6 hours PRN 1
  • Hospitalized children: Start low and increase gradually; in severe disorders, 50-100 mg daily (or 200+ mg in older children) may be necessary 1
  • Little evidence that doses beyond 500 mg/day further enhance behavior improvement in severely disturbed patients 1

References

Research

Chlorpromazine dose for people with schizophrenia.

The Cochrane database of systematic reviews, 2017

Guideline

palliative care version 1.2016.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Research

Chlorpromazine dose for people with schizophrenia.

The Cochrane database of systematic reviews, 2009

Related Questions

What are the recommended dosing guidelines for chlorpromazine (including oral and intramuscular routes) for adults, children, adolescents, and elderly patients, and how should the dose be adjusted in patients with hepatic or renal impairment?
How often can I increase the dose of Thorazine (chlorpromazine)?
What is the brand name of Chlorpromazine?
What is the recommended dose of chlorpromazine (Thorazine) for treatment?
How should chlorpromazine (Thorazine) be dosed for an adult, including oral and intramuscular routes and adjustments for elderly or patients with hepatic or renal impairment?
What are the indications, dosing, contraindications, and adverse effects of Exforge (amlodipine/valsartan) for hypertension?
What is the appropriate management of hospital‑acquired bronchopneumonia in a patient with an ectopic ACTH‑secreting tumor causing Cushing’s syndrome?
How should I evaluate and manage an adult female patient with new-onset chest tightness, no pain, that started after sexual activity, overheating, and vomiting?
In a patient with hospital‑acquired bronchopneumonia and severe immunosuppression from ectopic ACTH‑driven Cushing’s syndrome, what empiric broad‑spectrum antibiotics and antifungal therapy should be initiated?
What ICD‑9‑CM codes and documentation wording should be used for a hand‑surgery referral for a patient 9 days after a 2 cm left lateral finger laceration repaired with sutures, now with persistent numbness and tingling distal to the wound and no signs of infection?
What are the physiologic aspects and optimal management of perinatal asphyxia, and what is the role of magnesium sulfate in its treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.